3
Orphan Designations
0
FDA Approvals
10
Rare Diseases
0
News Articles
| Disease | Drug(s) | Designation | Approved |
|---|---|---|---|
| chronic graft versus host disease | Fampridine | Orphan Designation | - |
| chronic inflammatory demyelinating polyradiculoneuropathy | Fampridine | Orphan Designation | - |
| chronic primary adrenal insufficiency | Fampridine | Orphan Designation | - |
| congenital lethal erythroderma | Ampyra | Orphan Designation | - |
| multiple sclerosis | Ampyra | Orphan Designation | - |
| post-treatment Lyme disease syndrome | Ampyra | Orphan Designation | - |
| primary progressive multiple sclerosis | Ampyra | Orphan Designation | - |
| primary sclerosing cholangitis | recombinant, fully-human, IgG4 immunoglobulin with antigen-binding specificity for human vascular adhesion protein-1 (VAP-1) | Orphan Designation | - |
| progressive relapsing multiple sclerosis | Ampyra | Orphan Designation | - |
| secondary progressive multiple sclerosis | Ampyra | Orphan Designation | - |